“Keaping” an Eye on the NRF2 Signature Score: Expanding Its Applicability in Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference5 articles.
1. Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks;Xu;Theranostics,2023
2. KEAP1/NFE2L2 pathway signature outperforms KEAP1/NFE2L2 mutation status and reveals alternative pathway-activating mutations in non-small cell lung cancer;Arolt;J Thorac Oncol,2023
3. Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers;Okazaki;Nat Commun,2020
4. 3D culture models with CRISPR screens reveal hyperactive NRF2 as a prerequisite for spheroid formation via regulation of proliferation and ferroptosis;Takahashi;Mol Cell,2020
5. Proteomic analysis reveals a predominant NFE2L2 (NRF2) signature in canonical pathway and upstream regulator analysis of Leishmania-infected macrophages;de Menezes;Front Immunol,2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3